Logo-ipp
Submitted: 07 May 2023
Accepted: 06 Aug 2023
ePublished: 22 Aug 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

  Abstract View: 175

Review

Thymoma; clinical presentations, pathology, and prognostic factors – a surgery point of view

Hamid Reza Hemmati ORCID logo, Mohammad Memarian* ORCID logo

1 Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran
Mohammad Memarian, Email: draria2014@gmail.com, draria2014@semums.ac.ir

Abstract

Thymomas are rare tumors that can present with a wide range of clinical characteristics. The presence of symptoms and paraneoplastic syndromes, such as myasthenia gravis, along with the histological subtype and stage of the tumor, are important factors that guide the treatment approach and prognosis for patients with thymomas. The prognosis for thymoma varies depending on several factors, including the stage and type of the tumor, as well as the presence of associated autoimmune diseases. Generally, early-stage thymomas have a better prognosis compared to advanced-stage tumors. Regular follow-up with a multidisciplinary team, including oncologists and thoracic surgeons, is essential for long-term management and surveillance of patients.
Keywords: Thymoma, outcomes, Epithelial cells, Autoimmune disease, Myasthenia gravis, Paraneoplastic syndrome, Pure red cell aplasia, Malignancy, Surgery
Citation: Hemmati HR, Memarian M. Thymoma; clinical presentations, pathology, and prognostic factors – a surgery point of view. Immunopathol Persa. 2023;x(x):e40581. DOI:10.34172/ ipp.2023.40581.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 176

Your browser does not support the canvas element.


PDF Download: 0

Your browser does not support the canvas element.